Infrared imaging is an aid for patient education about GA

Publication
Article
Optometry Times JournalJuly digital edition 2024
Volume 16
Issue 07

Comanagement is a key component for treatment of disease.

Group of doctors discussing case findings Image credit: AdobeStock/bongkarn

Image credit: AdobeStock/bongkarn

In sister publication Ophthalmology Times’ Case of the Quarter series, Katherine Talcott, MD, shares 2 cases of geographic atrophy (GA) and highlights the importance of multimodal imaging to diagnose and monitor GA progression. Talcott is an assistant professor of ophthalmology at the Cole Eye Institute at Cleveland Clinic Lerner College of Medicine in Ohio.

Case 1: Visual decline

A 64-year-old woman was referred by her optometrist with the complaint of worsening vision over the previous 6 months, more so in the left eye. She also reported blobs in her vision. The patient had age-related macular degeneration (AMD) and had been followed by the optometrist for the past 5 years. She took AREDS vitamins (Bausch + Lomb) and monitored her vision using the Amsler grid. Her family history was positive for AMD; her father and uncles developed AMD in their 70s. The patient resided in a rural area and traveled
2.5 hours to her examinations.

The visual acuities (VAs) in the right and left eyes, respectively, were 20/20 and 20/25. The color fundus photographs showed areas of GA, which were responsible for her current visual difficulties. The optical coherence tomography (OCT) images ruled out intraretinal/subretinal fluid in both eyes. However, according to Talcott, there was diffuse retinal pigment epithelium (RPE) and ellipsoidal zone loss.

Talcott mentions the usefulness of the infrared images. “These images highlight the areas of atrophy very well,” she says. “These areas are not as well defined on the color fundus photographs.”

Autofluorescence images of the retina are also very helpful to show patients why they are having visual difficulties. This patient had significant areas of hypoautofluorescence in both eyes. Autofluorescence imaging is also helpful to determine the patient’s candidacy for treatment or research studies, Talcott explains.

The presence of hyperautofluorescence at the edge of the atrophic areas may suggest that the disease is rapidly progressive.

Each of the imaging modalities in this case conveyed different information about the treatments needed. “OCT is critical to ascertain that the patient does not have exudative changes, and [it] can assess for atrophy,” she says.

Moreover, Talcott explains the infrared images obtained at baseline can help pinpoint any changes in the eye that occur over time and the disease pattern. “[Although] OCT is the mainstay of the evaluation, the infrared images can help patients understand what is happening in the retina,” she comments.

Talcott also emphasizes the importance of regular monitoring of patients. Before treatment starts, she evaluates patients with GA every 6 months to rule out exudative changes. She also points out the scheduling of examinations based on the patient’s circumstances; in this case, the patient can be seen by a local optometrist to help cut down on travel to examinations far from home.

Case 2: Low-vision options

A 76-year-old woman with GA had progressive worsening of vision in her eye that interfered with reading and sewing. The right and left eye VAs were 20/25 and counting fingers, respectively, and had been stable for 3 years. The patient had a history of a macular macrovessel in the right eye and a choroidal hemangioma in the left eye.

The infrared images showed the macrovessel and areas of atrophy in the right eye corresponding to areas of loss of RPE and outer retinal changes on the OCT images. Diffuse areas of outer retinal loss were seen in the left eye. Multimodal imaging provided a better understanding of why the patient was having increasing difficulty seeing. A review of past infrared images showed that the atrophic areas had been enlarging and coalescing over the past year. The images from 3 years previously showed almost no atrophy.

Following a discussion about future visual problems, Talcott referred the patient to a local optometrist who specialized in low vision and visual rehabilitation for assessment of functional deficits and any potential interventional options to improve functionality.

An important takeaway from this case is the ability to look at the past images, which can provide a sense of the tempo of the disease regarding how fast changes are occurring and to determine whether there is anything else occurring in the retina.

Talcott also emphasizes the importance of the optometric component of this patient’s care. “There are certain things that retina specialists have difficulty offering a patient, such as a refraction, using certain low-vision tools, or evaluations for certain local services. A partnership to help with such patients is critical,” she concludes.

Recent Videos
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
© 2024 MJH Life Sciences

All rights reserved.